Sökning: onr:"swepub:oai:lup.lub.lu.se:dea1154f-9549-4848-b101-8728b1edebae" > Interleukin-6 as a ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03783naa a2200493 4500 | |
001 | oai:lup.lub.lu.se:dea1154f-9549-4848-b101-8728b1edebae | |
003 | SwePub | |
008 | 160401s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/21835612 URI |
024 | 7 | a https://doi.org/10.1158/1078-0432.CCR-11-09452 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Coward, Jermaine4 aut |
245 | 1 0 | a Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer |
264 | 1 | c 2011 |
520 | a Purpose: We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in ovarian cancer via abrogation of a tumor-promoting cytokine network. Experimental Design: We combined preclinical and in silico experiments with a phase 2 clinical trial of the anti-IL-6 antibody siltuximab in patients with platinum-resistant ovarian cancer. Results: Automated immunohistochemistry on tissue microarrays from 221 ovarian cancer cases showed that intensity of IL-6 staining in malignant cells significantly associated with poor prognosis. Treatment of ovarian cancer cells with siltuximab reduced constitutive cytokine and chemokine production and also inhibited IL-6 signaling, tumor growth, the tumor-associated macrophage infiltrate and angiogenesis in IL-6-producing intraperitoneal ovarian cancer xenografts. In the clinical trial, the primary endpoint was response rate as assessed by combined RECIST and CA125 criteria. One patient of eighteen evaluable had a partial response, while seven others had periods of disease stabilization. In patients treated for 6 months, there was a significant decline in plasma levels of IL-6-regulated CCL2, CXCL12, and VEGF. Gene expression levels of factors that were reduced by siltuximab treatment in the patients significantly correlated with high IL-6 pathway gene expression and macrophage markers in microarray analyses of ovarian cancer biopsies. Conclusion: IL-6 stimulates inflammatory cytokine production, tumor angiogenesis, and the tumor macrophage infiltrate in ovarian cancer and these actions can be inhibited by a neutralizing anti-IL-6 antibody in preclinical and clinical studies. Clin Cancer Res; 17(18); 6083-96. (C) 2011 AACR. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
700 | 1 | a Kulbe, Hagen4 aut |
700 | 1 | a Chakravarty, Probir4 aut |
700 | 1 | a Leader, David4 aut |
700 | 1 | a Vassileva, Vessela4 aut |
700 | 1 | a Leinster, D. Andrew4 aut |
700 | 1 | a Thompson, Richard4 aut |
700 | 1 | a Schioppa, Tiziana4 aut |
700 | 1 | a Nemeth, Jeffery4 aut |
700 | 1 | a Vermeulen, Jessica4 aut |
700 | 1 | a Singh, Naveena4 aut |
700 | 1 | a Avril, Norbert4 aut |
700 | 1 | a Cummings, Jeff4 aut |
700 | 1 | a Rexhepaj, Elton4 aut |
700 | 1 | a Jirström, Karinu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pat-kji |
700 | 1 | a Gallagher, William M.4 aut |
700 | 1 | a Brennan, Donal J.4 aut |
700 | 1 | a McNeish, Iain A.4 aut |
700 | 1 | a Balkwill, Frances R.4 aut |
710 | 2 | a Tumörmikromiljöb Sektion I4 org |
773 | 0 | t Clinical Cancer Researchg 17:18, s. 6083-6096q 17:18<6083-6096x 1078-0432 |
856 | 4 | u http://dx.doi.org/10.1158/1078-0432.CCR-11-0945y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/2183561 |
856 | 4 8 | u https://doi.org/10.1158/1078-0432.CCR-11-0945 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.